• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to: "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: A retrospective case series".

作者信息

Villani Alessia, Costa Claudia, Fabbrocini Gabriella, Cappello Milena, Scalvenzi Massimiliano

机构信息

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

出版信息

J Am Acad Dermatol. 2020 Sep;83(3):e201-e202. doi: 10.1016/j.jaad.2020.03.124. Epub 2020 May 4.

DOI:10.1016/j.jaad.2020.03.124
PMID:32376431
Abstract
摘要

相似文献

1
Reply to: "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: A retrospective case series".回复：“维莫德吉每日给药与周一至周五给药治疗局部晚期基底细胞癌（laBCC）和基底细胞痣综合征的比较：一项回顾性病例系列研究”
J Am Acad Dermatol. 2020 Sep;83(3):e201-e202. doi: 10.1016/j.jaad.2020.03.124. Epub 2020 May 4.
2
Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series.维莫德吉每日给药与周一至周五给药治疗局部晚期基底细胞癌和基底细胞痣综合征的比较：一项回顾性病例系列研究。
J Am Acad Dermatol. 2020 Jun;82(6):1539-1542. doi: 10.1016/j.jaad.2020.02.050. Epub 2020 Feb 21.
3
Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.刺猬通路抑制用于局部晚期眼周基底细胞癌和基底细胞痣综合征
Am J Ophthalmol. 2015 Aug;160(2):220-227.e2. doi: 10.1016/j.ajo.2015.04.040. Epub 2015 Apr 30.
4
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.基底细胞痣综合征患者中 hedgehog 通路的抑制：多中心、随机、双盲、安慰剂对照、2 期临床试验的最终结果。
Lancet Oncol. 2016 Dec;17(12):1720-1731. doi: 10.1016/S1470-2045(16)30566-6. Epub 2016 Nov 10.
5
Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin-Goltz syndrome: A retrospective study.六例诊断为戈林-戈尔茨综合征患者的基底细胞癌组织学亚型分析及其对维莫德吉的相对反应：一项回顾性研究。
J Eur Acad Dermatol Venereol. 2024 Apr;38(4):e339-e341. doi: 10.1111/jdv.19608. Epub 2023 Nov 10.
6
Comment on basal cell carcinoma rebound after cessation of vismodegib in an individual with basal cell nevus syndrome.对基底细胞痣综合征患者停用维莫德吉后基底细胞癌复发的评论。
Dermatol Surg. 2013 Sep;39(9):1413-4. doi: 10.1111/dsu.12250. Epub 2013 May 17.
7
Vismodegib in advanced basal-cell carcinoma.维莫德吉用于晚期基底细胞癌
N Engl J Med. 2012 Sep 6;367(10):970; author reply 970-1. doi: 10.1056/NEJMc1208003.
8
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.Hedgehog 通路抑制剂治疗局部晚期和转移性基底细胞癌：干预性研究的系统评价和汇总分析。
JAMA Dermatol. 2016 Jul 1;152(7):816-24. doi: 10.1001/jamadermatol.2016.0780.
9
Trichodysplasia spinulosa in gorlin syndrome treated with vismodegib-reply.维莫德吉治疗戈林综合征中的棘状毛发发育异常——回复
JAMA Dermatol. 2015 Apr;151(4):459. doi: 10.1001/jamadermatol.2014.4388.
10
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial.维莫德吉治疗晚期基底细胞癌患者：国际开放标签试验STEVIE的初步分析
Eur J Cancer. 2017 Nov;86:334-348. doi: 10.1016/j.ejca.2017.08.022. Epub 2017 Nov 5.

引用本文的文献

1
Retrospective Real-Life Data, Efficacy and Safety of Vismodegib Treatment in Patients with Advanced and Multiple Basal Cell Carcinoma: 3-Year Experience from a Spanish Center.回顾性真实世界数据：维莫德吉治疗晚期和多发性基底细胞癌患者的疗效和安全性：来自西班牙中心的 3 年经验。
Int J Environ Res Public Health. 2023 May 15;20(10):5824. doi: 10.3390/ijerph20105824.
2
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives.晚期基底细胞癌的长期管理：当前挑战与未来展望
Cancers (Basel). 2022 Sep 20;14(19):4547. doi: 10.3390/cancers14194547.